Nusano

Nusano is a technology-driven company aiming to solve critical supply shortages in the medical radioisotope market, which is vital for emerging cancer treatments. Its core innovation is a patented particle acceleration and ion source platform designed to produce isotopes more efficiently and affordably than traditional methods. Beyond healthcare, Nusano is exploring applications in nuclear waste management, energy, and mineral recovery. The company is in a pre-revenue, capital-intensive build-out phase, constructing a major production facility in West Valley City, Utah.

Proprietary particle acceleration and high-intensity ion source technology for the production of radioisotopes. Aims to be more efficient and scalable than reactors and cyclotrons, with applications in healthcare, energy (waste acceleration, fuel creation), and critical minerals recovery.

Nusano competes with traditional radioisotope suppliers including government-owned nuclear reactors (e.g., in Canada, Europe), networks of cyclotrons, and large commercial players like Curium, BWXT, and ITM Isotope Technologies Munich SE. Its differentiation is based on its proprietary accelerator technology promising higher yields and a more stable domestic (US) supply chain.